Home/Filings/4/0001104659-23-001224
4//SEC Filing

Riddell Alastair 4

Accession 0001104659-23-001224

CIK 0001604191other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 8:53 AM ET

Size

5.2 KB

Accession

0001104659-23-001224

Insider Transaction Report

Form 4
Period: 2023-01-03
Transactions
  • Award

    Common Stock

    2023-01-03+84,74585,185 total
Footnotes (2)
  • [F1]On January 3, 2023, the Reporting Person was granted 84,745 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning March 31, 2023.
  • [F2]Includes unvested RSUs.

Issuer

First Wave BioPharma, Inc.

CIK 0001604191

Entity typeother

Related Parties

1
  • filerCIK 0001681349

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:53 AM ET
Size
5.2 KB